Novartis to acquire MorphoSys for $2.9B



Novartis AG announced in an official statement on Monday that it will acquire MorphoSys AG, the German-based, global biopharmaceutical company for $2.9 billion.

Novartis will acquire MorphoSys for &e…

About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento